John Kappler
Concepts (933)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 239 | 2021 | 1982 | 6.100 |
Why?
| | Receptors, Antigen, T-Cell | 125 | 2024 | 668 | 5.770 |
Why?
| | Histocompatibility Antigens Class II | 80 | 2021 | 364 | 5.370 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 64 | 2024 | 331 | 4.930 |
Why?
| | CD4-Positive T-Lymphocytes | 55 | 2024 | 1129 | 3.930 |
Why?
| | Major Histocompatibility Complex | 56 | 2024 | 229 | 3.710 |
Why?
| | Thymus Gland | 59 | 2024 | 311 | 2.600 |
Why?
| | Peptide Fragments | 24 | 2021 | 699 | 2.470 |
Why?
| | Peptides | 48 | 2021 | 998 | 2.420 |
Why?
| | Hybridomas | 74 | 2019 | 234 | 2.310 |
Why?
| | Lymphocyte Activation | 81 | 2020 | 1126 | 2.080 |
Why?
| | Antigens | 50 | 2021 | 347 | 1.880 |
Why?
| | Histocompatibility Antigens | 17 | 2019 | 102 | 1.770 |
Why?
| | Mice | 331 | 2024 | 18365 | 1.750 |
Why?
| | Epitopes, T-Lymphocyte | 9 | 2021 | 175 | 1.650 |
Why?
| | H-2 Antigens | 38 | 2011 | 111 | 1.530 |
Why?
| | B-Lymphocytes | 61 | 2017 | 877 | 1.510 |
Why?
| | Animals | 371 | 2024 | 38109 | 1.480 |
Why?
| | Autoantigens | 23 | 2021 | 429 | 1.380 |
Why?
| | Amino Acid Sequence | 72 | 2019 | 2157 | 1.350 |
Why?
| | Epitopes | 47 | 2021 | 485 | 1.300 |
Why?
| | Autoimmunity | 13 | 2021 | 927 | 1.300 |
Why?
| | Berylliosis | 10 | 2021 | 202 | 1.230 |
Why?
| | Molecular Sequence Data | 68 | 2015 | 2931 | 1.130 |
Why?
| | Enterotoxins | 26 | 2009 | 89 | 1.100 |
Why?
| | Protein Binding | 36 | 2021 | 2276 | 1.100 |
Why?
| | Models, Molecular | 29 | 2018 | 1619 | 1.090 |
Why?
| | Antigen Presentation | 17 | 2021 | 205 | 1.090 |
Why?
| | Autoimmune Diseases | 7 | 2021 | 463 | 1.080 |
Why?
| | Immune Tolerance | 31 | 2024 | 379 | 1.070 |
Why?
| | Histocompatibility Antigens Class I | 12 | 2018 | 202 | 0.990 |
Why?
| | Immunologic Memory | 26 | 2020 | 366 | 0.950 |
Why?
| | Beryllium | 8 | 2021 | 161 | 0.940 |
Why?
| | Diabetes Mellitus, Type 1 | 16 | 2021 | 3890 | 0.940 |
Why?
| | Antibodies, Monoclonal | 55 | 2020 | 1524 | 0.910 |
Why?
| | Baculoviridae | 9 | 2015 | 44 | 0.910 |
Why?
| | HLA-DP beta-Chains | 10 | 2021 | 87 | 0.880 |
Why?
| | Alleles | 13 | 2017 | 881 | 0.880 |
Why?
| | CD8-Positive T-Lymphocytes | 24 | 2021 | 917 | 0.860 |
Why?
| | Insulin | 11 | 2024 | 2507 | 0.850 |
Why?
| | Interleukin-2 | 37 | 2015 | 437 | 0.820 |
Why?
| | Superantigens | 18 | 2002 | 70 | 0.780 |
Why?
| | Antigens, Surface | 24 | 2011 | 157 | 0.730 |
Why?
| | Mice, Inbred C57BL | 102 | 2024 | 5997 | 0.720 |
Why?
| | Mice, Transgenic | 48 | 2024 | 2185 | 0.710 |
Why?
| | Cell Line | 41 | 2021 | 2882 | 0.670 |
Why?
| | Lysosomes | 2 | 2021 | 128 | 0.670 |
Why?
| | Cathepsins | 1 | 2021 | 24 | 0.670 |
Why?
| | Antigens, Neoplasm | 8 | 2021 | 272 | 0.660 |
Why?
| | HLA-DR Antigens | 9 | 2016 | 220 | 0.660 |
Why?
| | T-Lymphocyte Subsets | 19 | 2013 | 415 | 0.640 |
Why?
| | Peptide Library | 6 | 2013 | 95 | 0.640 |
Why?
| | Protein Conformation | 21 | 2018 | 946 | 0.630 |
Why?
| | Adjuvants, Immunologic | 12 | 2016 | 245 | 0.620 |
Why?
| | Flow Cytometry | 28 | 2015 | 1173 | 0.600 |
Why?
| | Islets of Langerhans | 4 | 2021 | 833 | 0.590 |
Why?
| | Immunoglobulin G | 10 | 2017 | 893 | 0.570 |
Why?
| | Genes, MHC Class II | 18 | 2014 | 76 | 0.570 |
Why?
| | Base Sequence | 36 | 2016 | 2191 | 0.560 |
Why?
| | Mammary Tumor Virus, Mouse | 12 | 1995 | 45 | 0.550 |
Why?
| | Chromogranin A | 2 | 2015 | 43 | 0.530 |
Why?
| | Binding Sites | 20 | 2021 | 1331 | 0.510 |
Why?
| | Mice, Inbred BALB C | 48 | 2021 | 1253 | 0.510 |
Why?
| | Membrane Proteins | 14 | 2020 | 1167 | 0.500 |
Why?
| | Amino Acids | 5 | 2022 | 522 | 0.500 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 27 | 0.490 |
Why?
| | Mice, Inbred NOD | 11 | 2020 | 610 | 0.490 |
Why?
| | Ikaros Transcription Factor | 2 | 2013 | 23 | 0.470 |
Why?
| | Antigen-Presenting Cells | 21 | 2015 | 160 | 0.470 |
Why?
| | Lymphocyte Cooperation | 21 | 1990 | 50 | 0.460 |
Why?
| | Proto-Oncogene Proteins | 12 | 2009 | 623 | 0.460 |
Why?
| | Complementarity Determining Regions | 8 | 2012 | 53 | 0.460 |
Why?
| | Immunity, Cellular | 16 | 2010 | 272 | 0.450 |
Why?
| | CD3 Complex | 10 | 2018 | 111 | 0.450 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 97 | 0.450 |
Why?
| | Alum Compounds | 6 | 2016 | 26 | 0.450 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 12 | 2007 | 241 | 0.440 |
Why?
| | Hypersensitivity | 3 | 2016 | 252 | 0.440 |
Why?
| | Evolution, Molecular | 4 | 2019 | 515 | 0.430 |
Why?
| | Histone Demethylases | 3 | 2020 | 38 | 0.420 |
Why?
| | bcl-2-Associated X Protein | 4 | 2006 | 54 | 0.420 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 18 | 1991 | 100 | 0.420 |
Why?
| | Gene Expression Regulation | 22 | 2015 | 2609 | 0.410 |
Why?
| | Immunoglobulin Variable Region | 11 | 2012 | 80 | 0.410 |
Why?
| | Thymoma | 5 | 2012 | 36 | 0.410 |
Why?
| | Antibody Formation | 21 | 2010 | 294 | 0.400 |
Why?
| | Mice, Inbred Strains | 36 | 2000 | 397 | 0.400 |
Why?
| | Mutation | 25 | 2022 | 4099 | 0.400 |
Why?
| | Apoptosis | 15 | 2011 | 2430 | 0.400 |
Why?
| | Conserved Sequence | 3 | 2009 | 245 | 0.390 |
Why?
| | Lymphocytes, Null | 1 | 2012 | 3 | 0.390 |
Why?
| | Spleen | 32 | 2016 | 508 | 0.390 |
Why?
| | HLA-DR4 Antigen | 2 | 2005 | 74 | 0.380 |
Why?
| | Lymphokines | 12 | 1984 | 130 | 0.380 |
Why?
| | Bacterial Toxins | 6 | 1997 | 110 | 0.380 |
Why?
| | Antigens, Viral | 10 | 2001 | 182 | 0.370 |
Why?
| | Crystallography, X-Ray | 10 | 2018 | 493 | 0.370 |
Why?
| | Protein Processing, Post-Translational | 8 | 2018 | 477 | 0.370 |
Why?
| | Apoptosis Regulatory Proteins | 10 | 2011 | 187 | 0.360 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 130 | 0.360 |
Why?
| | Protein Structure, Tertiary | 10 | 2021 | 862 | 0.360 |
Why?
| | Ligands | 13 | 2022 | 674 | 0.360 |
Why?
| | Staphylococcus aureus | 12 | 1999 | 460 | 0.350 |
Why?
| | Glycoproteins | 3 | 2011 | 355 | 0.350 |
Why?
| | Humans | 130 | 2025 | 144957 | 0.340 |
Why?
| | Cancer Vaccines | 5 | 2021 | 160 | 0.340 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 64 | 0.330 |
Why?
| | Antigens, Bacterial | 8 | 2013 | 127 | 0.330 |
Why?
| | Clone Cells | 22 | 2024 | 266 | 0.330 |
Why?
| | Toll-Like Receptor 7 | 4 | 2016 | 43 | 0.330 |
Why?
| | Carrier Proteins | 10 | 2009 | 737 | 0.320 |
Why?
| | Cells, Cultured | 36 | 2021 | 4155 | 0.320 |
Why?
| | Interferon-gamma | 14 | 2016 | 784 | 0.320 |
Why?
| | B-Lymphocyte Subsets | 4 | 2020 | 80 | 0.320 |
Why?
| | Antibodies | 10 | 2009 | 403 | 0.320 |
Why?
| | Cell Differentiation | 28 | 2021 | 2050 | 0.300 |
Why?
| | Proinsulin | 2 | 2021 | 51 | 0.290 |
Why?
| | Ovalbumin | 21 | 2011 | 190 | 0.290 |
Why?
| | Signal Transduction | 17 | 2016 | 5233 | 0.280 |
Why?
| | CD11c Antigen | 5 | 2020 | 40 | 0.280 |
Why?
| | Nickel | 2 | 2012 | 64 | 0.280 |
Why?
| | Immunotherapy | 5 | 2021 | 657 | 0.280 |
Why?
| | Cross Reactions | 10 | 2012 | 130 | 0.270 |
Why?
| | Gene Expression | 11 | 2017 | 1490 | 0.270 |
Why?
| | Amino Acid Motifs | 7 | 2019 | 224 | 0.270 |
Why?
| | HLA-DQ Antigens | 6 | 2019 | 173 | 0.270 |
Why?
| | Immunoglobulin Fab Fragments | 3 | 2006 | 56 | 0.260 |
Why?
| | Cytokines | 13 | 2020 | 2065 | 0.260 |
Why?
| | beta 2-Microglobulin | 4 | 2010 | 47 | 0.260 |
Why?
| | Arthritis, Rheumatoid | 5 | 2014 | 1169 | 0.250 |
Why?
| | Cytochrome c Group | 5 | 2002 | 43 | 0.250 |
Why?
| | Insecta | 4 | 2009 | 74 | 0.240 |
Why?
| | Histones | 4 | 2018 | 670 | 0.240 |
Why?
| | Dendritic Cells | 7 | 2013 | 499 | 0.240 |
Why?
| | Cell Proliferation | 10 | 2020 | 2499 | 0.230 |
Why?
| | Kinetics | 18 | 2021 | 1629 | 0.230 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2017 | 239 | 0.230 |
Why?
| | HLA-D Antigens | 3 | 1998 | 30 | 0.230 |
Why?
| | Cell Survival | 18 | 2009 | 1098 | 0.220 |
Why?
| | Eicosapentaenoic Acid | 1 | 2025 | 36 | 0.220 |
Why?
| | Staphylococcus | 5 | 1994 | 75 | 0.220 |
Why?
| | Docosahexaenoic Acids | 1 | 2025 | 83 | 0.210 |
Why?
| | Transcription, Genetic | 8 | 2020 | 1496 | 0.210 |
Why?
| | Interleukin-12 | 2 | 2016 | 117 | 0.210 |
Why?
| | Protein Folding | 2 | 2021 | 279 | 0.210 |
Why?
| | Herpesviridae Infections | 2 | 2017 | 150 | 0.210 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2025 | 142 | 0.200 |
Why?
| | T-Lymphocytes, Helper-Inducer | 9 | 1989 | 131 | 0.200 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2025 | 124 | 0.200 |
Why?
| | Macromolecular Substances | 17 | 2003 | 224 | 0.200 |
Why?
| | Surface Plasmon Resonance | 5 | 2021 | 89 | 0.200 |
Why?
| | Macrophages | 19 | 2011 | 1511 | 0.200 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2020 | 29 | 0.200 |
Why?
| | DNA | 12 | 2016 | 1464 | 0.190 |
Why?
| | T-Cell Antigen Receptor Specificity | 3 | 2011 | 45 | 0.190 |
Why?
| | Germ Cells | 2 | 2016 | 66 | 0.190 |
Why?
| | Concanavalin A | 18 | 1990 | 71 | 0.190 |
Why?
| | Mice, Knockout | 17 | 2024 | 3125 | 0.190 |
Why?
| | Receptors, Cell Surface | 3 | 2020 | 377 | 0.190 |
Why?
| | Antiviral Agents | 2 | 2021 | 768 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 10 | 2017 | 851 | 0.190 |
Why?
| | Natural Killer T-Cells | 2 | 2013 | 67 | 0.190 |
Why?
| | T-Box Domain Proteins | 4 | 2020 | 106 | 0.190 |
Why?
| | Cell Death | 13 | 2006 | 383 | 0.180 |
Why?
| | Lung | 7 | 2021 | 4109 | 0.180 |
Why?
| | Oligonucleotide Array Sequence Analysis | 5 | 2008 | 758 | 0.180 |
Why?
| | Neoplasms, Experimental | 3 | 2021 | 173 | 0.180 |
Why?
| | Vaccines, Subunit | 3 | 2012 | 53 | 0.180 |
Why?
| | Polymorphism, Genetic | 6 | 2012 | 612 | 0.180 |
Why?
| | Immune System | 5 | 2013 | 179 | 0.180 |
Why?
| | Homeostasis | 5 | 2007 | 640 | 0.180 |
Why?
| | Transfection | 17 | 2009 | 940 | 0.180 |
Why?
| | Recombinant Proteins | 7 | 2005 | 1371 | 0.180 |
Why?
| | Sequence Homology, Amino Acid | 6 | 2019 | 396 | 0.180 |
Why?
| | Structure-Activity Relationship | 10 | 2006 | 570 | 0.180 |
Why?
| | Neoplasms | 5 | 2021 | 2884 | 0.170 |
Why?
| | Peptidyl Transferases | 1 | 2021 | 8 | 0.170 |
Why?
| | Crystallization | 2 | 2015 | 146 | 0.170 |
Why?
| | Bcl-2-Like Protein 11 | 9 | 2009 | 37 | 0.170 |
Why?
| | Chemokine CCL4 | 1 | 2021 | 31 | 0.170 |
Why?
| | Aging | 8 | 2015 | 1966 | 0.170 |
Why?
| | Chemokine CCL3 | 1 | 2021 | 26 | 0.170 |
Why?
| | Pancreas | 2 | 2021 | 342 | 0.170 |
Why?
| | HLA-C Antigens | 1 | 2021 | 36 | 0.170 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 9 | 2011 | 331 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 1 | 2005 | 579 | 0.170 |
Why?
| | Autoantibodies | 6 | 2017 | 1504 | 0.170 |
Why?
| | Cloning, Molecular | 12 | 2000 | 541 | 0.160 |
Why?
| | Female | 73 | 2025 | 78376 | 0.160 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 988 | 0.160 |
Why?
| | Epitope Mapping | 4 | 2015 | 61 | 0.160 |
Why?
| | Immunoglobulin Idiotypes | 6 | 1986 | 28 | 0.160 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 18 | 0.160 |
Why?
| | Synovial Fluid | 2 | 2000 | 67 | 0.160 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 32 | 0.160 |
Why?
| | Hemolytic Plaque Technique | 16 | 1983 | 28 | 0.160 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2020 | 636 | 0.160 |
Why?
| | Substrate Specificity | 3 | 2017 | 392 | 0.160 |
Why?
| | RNA Polymerase II | 2 | 2020 | 351 | 0.160 |
Why?
| | Glycosaminoglycans | 1 | 2000 | 74 | 0.150 |
Why?
| | Animal Fur | 1 | 2019 | 1 | 0.150 |
Why?
| | Haptens | 4 | 1988 | 21 | 0.150 |
Why?
| | Nerve Growth Factors | 1 | 2000 | 78 | 0.150 |
Why?
| | Genes | 15 | 1990 | 226 | 0.150 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 253 | 0.150 |
Why?
| | Inflammation | 5 | 2020 | 2880 | 0.150 |
Why?
| | CD8 Antigens | 9 | 2006 | 72 | 0.150 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2020 | 93 | 0.150 |
Why?
| | Membrane Glycoproteins | 6 | 2013 | 496 | 0.150 |
Why?
| | Cell Separation | 13 | 2014 | 307 | 0.150 |
Why?
| | Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.150 |
Why?
| | Lipocalins | 1 | 2019 | 35 | 0.150 |
Why?
| | DNA Mutational Analysis | 2 | 2009 | 409 | 0.150 |
Why?
| | Methyltransferases | 1 | 2020 | 74 | 0.150 |
Why?
| | Cell Line, Transformed | 2 | 2018 | 140 | 0.150 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2020 | 95 | 0.150 |
Why?
| | Mice, Inbred DBA | 20 | 2002 | 187 | 0.150 |
Why?
| | Vaccines | 3 | 2016 | 389 | 0.150 |
Why?
| | Lymph Nodes | 12 | 2013 | 502 | 0.150 |
Why?
| | Interleukin-4 | 6 | 2008 | 206 | 0.140 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1999 | 55 | 0.140 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2014 | 389 | 0.140 |
Why?
| | Protein Structure, Secondary | 5 | 2012 | 369 | 0.140 |
Why?
| | Molecular Weight | 12 | 2006 | 327 | 0.140 |
Why?
| | Genetic Linkage | 8 | 2002 | 273 | 0.140 |
Why?
| | Disease Models, Animal | 7 | 2015 | 4569 | 0.140 |
Why?
| | Cell Division | 12 | 2008 | 766 | 0.140 |
Why?
| | Antibody Specificity | 11 | 2020 | 181 | 0.140 |
Why?
| | Mice, Mutant Strains | 8 | 2014 | 299 | 0.140 |
Why?
| | Th2 Cells | 3 | 2010 | 171 | 0.140 |
Why?
| | Species Specificity | 12 | 2006 | 574 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 276 | 0.140 |
Why?
| | Genome | 2 | 2000 | 306 | 0.140 |
Why?
| | Hybrid Cells | 4 | 1997 | 49 | 0.140 |
Why?
| | Antigens, Ly | 4 | 1988 | 40 | 0.140 |
Why?
| | Transcription Factors | 5 | 2024 | 1742 | 0.140 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 100 | 0.130 |
Why?
| | Gene Expression Profiling | 5 | 2013 | 1786 | 0.130 |
Why?
| | bcl-X Protein | 4 | 2006 | 45 | 0.130 |
Why?
| | Hemocyanins | 9 | 1983 | 61 | 0.130 |
Why?
| | Cell Line, Tumor | 6 | 2021 | 3550 | 0.130 |
Why?
| | Vaccination | 8 | 2010 | 1423 | 0.130 |
Why?
| | Herpesviridae | 1 | 2017 | 22 | 0.130 |
Why?
| | Cat Diseases | 1 | 2017 | 25 | 0.130 |
Why?
| | Interleukin-7 | 4 | 2004 | 65 | 0.130 |
Why?
| | Spodoptera | 3 | 2021 | 40 | 0.130 |
Why?
| | Fluorescent Antibody Technique | 6 | 2011 | 370 | 0.130 |
Why?
| | Erythrocytes | 25 | 2002 | 757 | 0.120 |
Why?
| | Solubility | 5 | 2003 | 242 | 0.120 |
Why?
| | Friend murine leukemia virus | 1 | 2016 | 31 | 0.120 |
Why?
| | Deoxyribonucleases | 1 | 2016 | 24 | 0.120 |
Why?
| | Cell Communication | 8 | 2013 | 324 | 0.120 |
Why?
| | Antibody-Producing Cells | 11 | 1983 | 29 | 0.120 |
Why?
| | Germ-Line Mutation | 2 | 2009 | 175 | 0.120 |
Why?
| | Allergens | 1 | 2019 | 384 | 0.120 |
Why?
| | Antibody Affinity | 4 | 2020 | 60 | 0.120 |
Why?
| | Immunologic Deficiency Syndromes | 3 | 2007 | 65 | 0.120 |
Why?
| | Immunity | 3 | 2007 | 139 | 0.120 |
Why?
| | Mice, Inbred AKR | 10 | 1989 | 37 | 0.120 |
Why?
| | Thymocytes | 2 | 2013 | 34 | 0.120 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2008 | 193 | 0.120 |
Why?
| | Protein Precursors | 1 | 2016 | 137 | 0.120 |
Why?
| | Clonal Anergy | 3 | 2006 | 54 | 0.120 |
Why?
| | Binding, Competitive | 9 | 2010 | 193 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 6 | 2021 | 2365 | 0.120 |
Why?
| | Methylation | 5 | 2018 | 242 | 0.110 |
Why?
| | Cytotoxicity, Immunologic | 8 | 2010 | 223 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 3 | 1988 | 420 | 0.110 |
Why?
| | Mast Cells | 2 | 2009 | 146 | 0.110 |
Why?
| | History, 20th Century | 4 | 2016 | 325 | 0.110 |
Why?
| | Influenza A virus | 2 | 2013 | 113 | 0.110 |
Why?
| | Cerebroside-Sulfatase | 2 | 1993 | 3 | 0.110 |
Why?
| | Leukodystrophy, Metachromatic | 2 | 1993 | 4 | 0.110 |
Why?
| | Reactive Oxygen Species | 3 | 2003 | 621 | 0.110 |
Why?
| | T-Lymphocytes, Cytotoxic | 4 | 2011 | 177 | 0.110 |
Why?
| | RNA, Messenger | 11 | 2022 | 2832 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2006 | 1217 | 0.110 |
Why?
| | Self Tolerance | 2 | 1996 | 26 | 0.110 |
Why?
| | Polymerase Chain Reaction | 7 | 2016 | 1054 | 0.110 |
Why?
| | Interleukin-15 | 5 | 2006 | 97 | 0.110 |
Why?
| | Peptide Biosynthesis | 1 | 1994 | 13 | 0.110 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 341 | 0.110 |
Why?
| | Receptors, Immunologic | 3 | 2020 | 206 | 0.110 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2011 | 381 | 0.110 |
Why?
| | Ribosomal Proteins | 1 | 2014 | 91 | 0.100 |
Why?
| | Breast Neoplasms | 2 | 2018 | 2456 | 0.100 |
Why?
| | Cysteine | 2 | 2010 | 210 | 0.100 |
Why?
| | Mutagenesis | 3 | 2021 | 192 | 0.100 |
Why?
| | Granuloma | 1 | 2014 | 96 | 0.100 |
Why?
| | Haplotypes | 4 | 1990 | 490 | 0.100 |
Why?
| | gamma-Globulins | 4 | 1983 | 14 | 0.100 |
Why?
| | Clonal Deletion | 4 | 2004 | 16 | 0.100 |
Why?
| | Immunity, Innate | 4 | 2021 | 846 | 0.100 |
Why?
| | Antigens, CD | 5 | 2001 | 555 | 0.100 |
Why?
| | Sodium | 1 | 2014 | 197 | 0.100 |
Why?
| | Hydrogen Bonding | 2 | 2008 | 169 | 0.100 |
Why?
| | HLA Antigens | 4 | 2018 | 225 | 0.100 |
Why?
| | Gammaherpesvirinae | 1 | 2013 | 45 | 0.100 |
Why?
| | Nucleoproteins | 1 | 2013 | 38 | 0.100 |
Why?
| | Chimera | 8 | 2009 | 61 | 0.100 |
Why?
| | Viral Proteins | 2 | 2009 | 355 | 0.100 |
Why?
| | Antigen-Antibody Reactions | 7 | 2021 | 50 | 0.100 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 80 | 0.100 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 31 | 0.090 |
Why?
| | Genes, Immunoglobulin | 3 | 1988 | 29 | 0.090 |
Why?
| | CD4 Antigens | 9 | 1998 | 139 | 0.090 |
Why?
| | Lymphocyte Depletion | 5 | 2001 | 132 | 0.090 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 172 | 0.090 |
Why?
| | Diabetes Mellitus | 1 | 2021 | 1098 | 0.090 |
Why?
| | Models, Immunological | 4 | 2008 | 100 | 0.090 |
Why?
| | Chromosome Mapping | 8 | 2002 | 510 | 0.090 |
Why?
| | B7-1 Antigen | 3 | 2004 | 55 | 0.090 |
Why?
| | Escherichia coli | 4 | 2013 | 855 | 0.090 |
Why?
| | Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 37 | 0.090 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2012 | 132 | 0.090 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 72 | 0.090 |
Why?
| | Dose-Response Relationship, Immunologic | 12 | 2000 | 76 | 0.090 |
Why?
| | Communicable Diseases | 1 | 1994 | 163 | 0.090 |
Why?
| | Amino Acid Substitution | 3 | 2021 | 304 | 0.090 |
Why?
| | Phagocytosis | 2 | 2011 | 299 | 0.090 |
Why?
| | Sheep | 20 | 1983 | 880 | 0.080 |
Why?
| | Intestinal Mucosa | 1 | 1997 | 676 | 0.080 |
Why?
| | Antilymphocyte Serum | 9 | 1981 | 61 | 0.080 |
Why?
| | Lipid A | 1 | 2011 | 28 | 0.080 |
Why?
| | Receptors, CXCR5 | 1 | 2011 | 27 | 0.080 |
Why?
| | Molecular Conformation | 2 | 2009 | 148 | 0.080 |
Why?
| | Th1 Cells | 2 | 2010 | 139 | 0.080 |
Why?
| | Glycosylation | 4 | 1994 | 172 | 0.080 |
Why?
| | Immunization | 8 | 2004 | 374 | 0.080 |
Why?
| | Trypsin | 5 | 2006 | 76 | 0.080 |
Why?
| | Male | 30 | 2025 | 72406 | 0.080 |
Why?
| | Aluminum | 1 | 2010 | 43 | 0.080 |
Why?
| | Gene Deletion | 2 | 2009 | 389 | 0.080 |
Why?
| | Crosses, Genetic | 7 | 2006 | 124 | 0.080 |
Why?
| | Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 9 | 0.080 |
Why?
| | Neoplasm Proteins | 1 | 2013 | 444 | 0.080 |
Why?
| | DNA, Recombinant | 4 | 2005 | 48 | 0.080 |
Why?
| | Lymphocyte Count | 4 | 2010 | 164 | 0.080 |
Why?
| | Complement C3 | 1 | 2011 | 191 | 0.080 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2009 | 12 | 0.080 |
Why?
| | Insulin-Secreting Cells | 2 | 2016 | 388 | 0.080 |
Why?
| | DNA-Binding Proteins | 3 | 2014 | 1500 | 0.080 |
Why?
| | In Vitro Techniques | 8 | 2000 | 1048 | 0.080 |
Why?
| | Chickens | 9 | 1994 | 191 | 0.080 |
Why?
| | Molecular Mimicry | 1 | 2009 | 37 | 0.080 |
Why?
| | Radiation Chimera | 6 | 2001 | 27 | 0.080 |
Why?
| | Leukemia, Lymphoid | 3 | 2006 | 27 | 0.080 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 14 | 0.080 |
Why?
| | Chronic Disease | 5 | 2021 | 1813 | 0.080 |
Why?
| | HLA-B Antigens | 1 | 2009 | 57 | 0.080 |
Why?
| | Histidine | 2 | 2003 | 66 | 0.080 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 76 | 0.080 |
Why?
| | Molecular Docking Simulation | 2 | 2021 | 124 | 0.080 |
Why?
| | Immunoglobulin Heavy Chains | 6 | 1988 | 85 | 0.080 |
Why?
| | Cell Membrane | 6 | 2004 | 706 | 0.080 |
Why?
| | Mice, Inbred C3H | 7 | 1993 | 251 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.070 |
Why?
| | Receptors, Interleukin-2 | 4 | 2003 | 64 | 0.070 |
Why?
| | Sequence Alignment | 2 | 2008 | 368 | 0.070 |
Why?
| | Immunity, Humoral | 2 | 2022 | 120 | 0.070 |
Why?
| | Time Factors | 12 | 2013 | 7183 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2003 | 561 | 0.070 |
Why?
| | RNA | 4 | 2010 | 940 | 0.070 |
Why?
| | Oligopeptides | 2 | 2001 | 269 | 0.070 |
Why?
| | Fluorescent Dyes | 2 | 2001 | 330 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 524 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2008 | 13 | 0.070 |
Why?
| | Gonadal Steroid Hormones | 1 | 2010 | 144 | 0.070 |
Why?
| | Lymphocytes | 6 | 1997 | 382 | 0.070 |
Why?
| | Chondroitin | 1 | 1988 | 6 | 0.070 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 37 | 0.070 |
Why?
| | Mass Spectrometry | 3 | 2020 | 750 | 0.070 |
Why?
| | Ubiquitination | 1 | 2008 | 118 | 0.070 |
Why?
| | Mice, Inbred CBA | 8 | 2001 | 57 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 47 | 0.070 |
Why?
| | Interleukin-6 | 3 | 2011 | 780 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor | 3 | 2003 | 163 | 0.070 |
Why?
| | Chondroitin Sulfates | 1 | 1988 | 35 | 0.070 |
Why?
| | Herpesvirus 4, Human | 1 | 2009 | 176 | 0.070 |
Why?
| | Interferon-beta | 2 | 2006 | 92 | 0.070 |
Why?
| | Protein Domains | 2 | 2020 | 313 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 116 | 0.070 |
Why?
| | Galactosylceramides | 1 | 2007 | 27 | 0.070 |
Why?
| | Cell Movement | 5 | 2013 | 965 | 0.070 |
Why?
| | Heterozygote | 2 | 2024 | 315 | 0.070 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 17 | 0.070 |
Why?
| | Blotting, Western | 3 | 2020 | 1187 | 0.070 |
Why?
| | Antigens, CD1d | 3 | 2013 | 68 | 0.060 |
Why?
| | Interferon-alpha | 2 | 2006 | 197 | 0.060 |
Why?
| | Phenotype | 10 | 2008 | 3164 | 0.060 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 16 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 5 | 2002 | 675 | 0.060 |
Why?
| | Bone Marrow Cells | 3 | 2016 | 320 | 0.060 |
Why?
| | Sequence Homology, Nucleic Acid | 7 | 1992 | 157 | 0.060 |
Why?
| | Open Reading Frames | 3 | 1992 | 132 | 0.060 |
Why?
| | Killer Cells, Natural | 2 | 2007 | 469 | 0.060 |
Why?
| | Poly I-C | 1 | 2006 | 57 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 509 | 0.060 |
Why?
| | Molecular Structure | 2 | 2003 | 501 | 0.060 |
Why?
| | Restriction Mapping | 3 | 1998 | 80 | 0.060 |
Why?
| | Arginine | 2 | 2018 | 262 | 0.060 |
Why?
| | Chemotaxis, Leukocyte | 2 | 2003 | 113 | 0.060 |
Why?
| | Protein Biosynthesis | 3 | 1992 | 458 | 0.060 |
Why?
| | Cell Culture Techniques | 3 | 2009 | 375 | 0.060 |
Why?
| | Proteins | 2 | 1982 | 1022 | 0.060 |
Why?
| | Moths | 3 | 1997 | 52 | 0.060 |
Why?
| | Hyaluronan Receptors | 3 | 2003 | 102 | 0.060 |
Why?
| | Jurkat Cells | 2 | 2009 | 114 | 0.060 |
Why?
| | Bone Marrow | 4 | 2009 | 306 | 0.060 |
Why?
| | Promoter Regions, Genetic | 4 | 2020 | 1258 | 0.060 |
Why?
| | Epithelium | 6 | 1997 | 314 | 0.060 |
Why?
| | Nitrophenols | 10 | 2004 | 29 | 0.060 |
Why?
| | Lipopolysaccharides | 8 | 2002 | 863 | 0.060 |
Why?
| | Proteolysis | 2 | 2018 | 173 | 0.050 |
Why?
| | Organ Culture Techniques | 6 | 1993 | 154 | 0.050 |
Why?
| | Oligonucleotides | 2 | 2004 | 151 | 0.050 |
Why?
| | Exons | 2 | 2000 | 358 | 0.050 |
Why?
| | Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.050 |
Why?
| | CD4-CD8 Ratio | 2 | 2002 | 23 | 0.050 |
Why?
| | Mice, Inbred A | 6 | 1984 | 48 | 0.050 |
Why?
| | Histocompatibility Antigen H-2D | 4 | 2010 | 20 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2020 | 3608 | 0.050 |
Why?
| | Phosphorylation | 4 | 2020 | 1733 | 0.050 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2003 | 7 | 0.050 |
Why?
| | Gene Library | 1 | 2004 | 126 | 0.050 |
Why?
| | Leukotriene B4 | 1 | 2003 | 37 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2004 | 138 | 0.050 |
Why?
| | Microtubule-Associated Proteins | 1 | 2005 | 196 | 0.050 |
Why?
| | CD28 Antigens | 2 | 2008 | 58 | 0.050 |
Why?
| | Luminescent Proteins | 2 | 2001 | 185 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2004 | 148 | 0.050 |
Why?
| | Selection, Genetic | 2 | 2019 | 256 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 22 | 0.050 |
Why?
| | NF-kappa B | 2 | 2004 | 662 | 0.050 |
Why?
| | Immunoblotting | 3 | 2008 | 300 | 0.050 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 9 | 0.050 |
Why?
| | Chemokine CCL5 | 1 | 2002 | 41 | 0.050 |
Why?
| | Talin | 1 | 2002 | 10 | 0.050 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 16 | 0.050 |
Why?
| | Anemia, Hemolytic, Autoimmune | 1 | 2002 | 14 | 0.050 |
Why?
| | Clodronic Acid | 1 | 2002 | 19 | 0.050 |
Why?
| | Serum Albumin, Bovine | 6 | 2011 | 62 | 0.050 |
Why?
| | Phosphoproteins | 1 | 2005 | 346 | 0.050 |
Why?
| | Leukocyte Common Antigens | 1 | 2002 | 88 | 0.050 |
Why?
| | Cell Fusion | 4 | 1989 | 49 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 138 | 0.050 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2002 | 433 | 0.050 |
Why?
| | DNA, Viral | 1 | 2004 | 358 | 0.040 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2002 | 92 | 0.040 |
Why?
| | Egg Proteins | 1 | 2001 | 20 | 0.040 |
Why?
| | Moloney murine leukemia virus | 1 | 2001 | 13 | 0.040 |
Why?
| | Genetic Vectors | 2 | 2001 | 337 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 848 | 0.040 |
Why?
| | Genotype | 4 | 2015 | 1835 | 0.040 |
Why?
| | Sf9 Cells | 1 | 2021 | 11 | 0.040 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 342 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2001 | 133 | 0.040 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1992 | 117 | 0.040 |
Why?
| | HIV Infections | 1 | 2016 | 3154 | 0.040 |
Why?
| | Interleukin-1 | 5 | 1997 | 961 | 0.040 |
Why?
| | Adoptive Transfer | 4 | 2004 | 198 | 0.040 |
Why?
| | Dimerization | 2 | 2001 | 194 | 0.040 |
Why?
| | Receptors, Fc | 2 | 2020 | 55 | 0.040 |
Why?
| | Allergy and Immunology | 1 | 2001 | 42 | 0.040 |
Why?
| | Calcium | 6 | 2004 | 1184 | 0.040 |
Why?
| | Borrelia burgdorferi Group | 1 | 2000 | 7 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 824 | 0.040 |
Why?
| | Perissodactyla | 8 | 1981 | 12 | 0.040 |
Why?
| | Temperature | 2 | 2003 | 679 | 0.040 |
Why?
| | Melanoma, Experimental | 1 | 2001 | 108 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 428 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2001 | 90 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2005 | 629 | 0.040 |
Why?
| | Models, Animal | 1 | 2002 | 392 | 0.040 |
Why?
| | Immunoglobulin E | 2 | 2019 | 315 | 0.040 |
Why?
| | Netrin-1 | 1 | 2000 | 15 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2021 | 96 | 0.040 |
Why?
| | Phorbol Esters | 1 | 2000 | 13 | 0.040 |
Why?
| | Middle Aged | 6 | 2025 | 35928 | 0.040 |
Why?
| | Biotinylation | 1 | 2000 | 37 | 0.040 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2001 | 134 | 0.040 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 43 | 0.040 |
Why?
| | Green Fluorescent Proteins | 3 | 2013 | 405 | 0.040 |
Why?
| | Survival Rate | 1 | 2025 | 2092 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2021 | 142 | 0.040 |
Why?
| | Immune Sera | 5 | 1984 | 77 | 0.040 |
Why?
| | Calorimetry | 1 | 2000 | 72 | 0.040 |
Why?
| | Haploidy | 1 | 1980 | 28 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2000 | 93 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 148 | 0.040 |
Why?
| | Circular Dichroism | 1 | 2000 | 150 | 0.040 |
Why?
| | B-Cell Activating Factor | 3 | 2006 | 21 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 156 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 261 | 0.040 |
Why?
| | Transcription Factor AP-1 | 1 | 2000 | 79 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2019 | 19 | 0.040 |
Why?
| | Mitochondria | 2 | 2004 | 984 | 0.040 |
Why?
| | Receptors, Complement 3d | 1 | 2020 | 142 | 0.040 |
Why?
| | Homozygote | 2 | 1991 | 199 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2011 | 36 | 0.040 |
Why?
| | Aged | 4 | 2025 | 25947 | 0.040 |
Why?
| | Hot Temperature | 2 | 2000 | 407 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 418 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 116 | 0.040 |
Why?
| | Retroviridae | 2 | 2013 | 101 | 0.040 |
Why?
| | Lipoproteins | 1 | 2000 | 169 | 0.040 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 1999 | 70 | 0.040 |
Why?
| | Mice, Nude | 3 | 2013 | 688 | 0.040 |
Why?
| | Vaccinia | 1 | 1999 | 20 | 0.040 |
Why?
| | Immunization, Secondary | 1 | 1999 | 91 | 0.040 |
Why?
| | Binding Sites, Antibody | 6 | 1991 | 41 | 0.040 |
Why?
| | Plasmids | 4 | 2001 | 379 | 0.040 |
Why?
| | fas Receptor | 4 | 2002 | 92 | 0.040 |
Why?
| | Horses | 8 | 1981 | 201 | 0.040 |
Why?
| | Rabbits | 6 | 1984 | 648 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 442 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 983 | 0.040 |
Why?
| | Computer Simulation | 1 | 2003 | 1026 | 0.040 |
Why?
| | Trinitrobenzenes | 5 | 1982 | 14 | 0.040 |
Why?
| | Recombination, Genetic | 4 | 1988 | 205 | 0.040 |
Why?
| | Fibroblasts | 4 | 2017 | 1034 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 244 | 0.040 |
Why?
| | Cell Cycle | 2 | 2020 | 597 | 0.040 |
Why?
| | Precipitin Tests | 3 | 2001 | 93 | 0.040 |
Why?
| | Trans-Activators | 2 | 2000 | 405 | 0.040 |
Why?
| | Coculture Techniques | 2 | 2013 | 246 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2013 | 381 | 0.030 |
Why?
| | Nucleosomes | 1 | 2020 | 165 | 0.030 |
Why?
| | Cartilage | 1 | 2000 | 198 | 0.030 |
Why?
| | Asparagine | 1 | 1998 | 35 | 0.030 |
Why?
| | DNA Repair | 1 | 2020 | 256 | 0.030 |
Why?
| | Dogs | 1 | 2019 | 438 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2000 | 249 | 0.030 |
Why?
| | Crystallography | 2 | 2007 | 28 | 0.030 |
Why?
| | Hemoglobins | 2 | 2001 | 384 | 0.030 |
Why?
| | Interferon Type I | 1 | 1999 | 145 | 0.030 |
Why?
| | Codon | 1 | 1998 | 94 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2000 | 321 | 0.030 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 1978 | 41 | 0.030 |
Why?
| | Receptors, Interferon | 2 | 2013 | 60 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 371 | 0.030 |
Why?
| | Caspases | 2 | 2014 | 232 | 0.030 |
Why?
| | Cricetinae | 3 | 1994 | 304 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 1999 | 311 | 0.030 |
Why?
| | Lupus Nephritis | 2 | 2006 | 70 | 0.030 |
Why?
| | Immunoprecipitation | 2 | 2008 | 151 | 0.030 |
Why?
| | Immunoglobulin Constant Regions | 3 | 1986 | 7 | 0.030 |
Why?
| | Collagen | 1 | 2000 | 456 | 0.030 |
Why?
| | Age Factors | 4 | 2017 | 3335 | 0.030 |
Why?
| | Receptors, IgE | 1 | 1997 | 43 | 0.030 |
Why?
| | Epithelial Cells | 2 | 2021 | 1126 | 0.030 |
Why?
| | Virus Diseases | 2 | 1992 | 216 | 0.030 |
Why?
| | Societies, Medical | 1 | 2001 | 887 | 0.030 |
Why?
| | Cats | 1 | 2017 | 228 | 0.030 |
Why?
| | Respiratory Hypersensitivity | 1 | 1997 | 65 | 0.030 |
Why?
| | Germinal Center | 1 | 2017 | 67 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2000 | 437 | 0.030 |
Why?
| | Columbidae | 2 | 1994 | 31 | 0.030 |
Why?
| | Phylogeny | 1 | 2021 | 1019 | 0.030 |
Why?
| | Chromatography, Gel | 3 | 2014 | 131 | 0.030 |
Why?
| | Young Adult | 3 | 2020 | 14126 | 0.030 |
Why?
| | Drug Contamination | 1 | 2016 | 52 | 0.030 |
Why?
| | Emulsions | 1 | 2016 | 57 | 0.030 |
Why?
| | High-Throughput Screening Assays | 1 | 2018 | 175 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 1996 | 76 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2016 | 116 | 0.030 |
Why?
| | C-Peptide | 1 | 2016 | 189 | 0.030 |
Why?
| | Hematopoiesis | 1 | 1997 | 194 | 0.030 |
Why?
| | Fetus | 3 | 1993 | 803 | 0.030 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| | Chemokine CCL21 | 1 | 2015 | 13 | 0.030 |
Why?
| | Down-Regulation | 3 | 2003 | 627 | 0.030 |
Why?
| | Immunoconjugates | 1 | 1997 | 137 | 0.030 |
Why?
| | Immunoglobulin Isotypes | 2 | 2008 | 35 | 0.030 |
Why?
| | Receptors, CCR7 | 1 | 2015 | 31 | 0.030 |
Why?
| | Imidazoles | 1 | 2016 | 254 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| | Static Electricity | 1 | 2015 | 113 | 0.030 |
Why?
| | Tumor Cells, Cultured | 4 | 2001 | 919 | 0.030 |
Why?
| | Adult | 6 | 2020 | 40506 | 0.030 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 2014 | 23 | 0.030 |
Why?
| | Antibody Diversity | 3 | 1989 | 16 | 0.030 |
Why?
| | Immunophenotyping | 3 | 2004 | 322 | 0.030 |
Why?
| | V(D)J Recombination | 1 | 2014 | 8 | 0.030 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2014 | 37 | 0.030 |
Why?
| | Cattle | 4 | 2011 | 1000 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 1994 | 69 | 0.030 |
Why?
| | Enzyme Activation | 3 | 2001 | 768 | 0.030 |
Why?
| | Glutamic Acid | 2 | 2010 | 251 | 0.030 |
Why?
| | Culture Techniques | 2 | 1973 | 67 | 0.030 |
Why?
| | Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 5 | 1999 | 27 | 0.030 |
Why?
| | Chromatography, Ion Exchange | 1 | 2014 | 57 | 0.030 |
Why?
| | Databases, Factual | 1 | 2000 | 1486 | 0.030 |
Why?
| | Endopeptidases | 1 | 1994 | 82 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 100 | 0.030 |
Why?
| | Receptors, Interleukin-7 | 2 | 2006 | 28 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 1993 | 32 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2003 | 2032 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 202 | 0.020 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2013 | 16 | 0.020 |
Why?
| | Thymectomy | 5 | 1975 | 15 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2013 | 18 | 0.020 |
Why?
| | Viral Envelope Proteins | 1 | 1994 | 98 | 0.020 |
Why?
| | Growth Substances | 2 | 1983 | 140 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2015 | 310 | 0.020 |
Why?
| | HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 427 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2014 | 169 | 0.020 |
Why?
| | Kidney | 2 | 2017 | 1496 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2013 | 65 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2017 | 672 | 0.020 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2013 | 47 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2025 | 11695 | 0.020 |
Why?
| | Vomiting | 1 | 1993 | 130 | 0.020 |
Why?
| | Prospective Studies | 1 | 2025 | 7997 | 0.020 |
Why?
| | Genes, MHC Class I | 2 | 2009 | 36 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.020 |
Why?
| | Dinoprostone | 2 | 1991 | 178 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 685 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 512 | 0.020 |
Why?
| | Zinc | 1 | 1995 | 295 | 0.020 |
Why?
| | Microsomes | 1 | 1992 | 33 | 0.020 |
Why?
| | DNA Restriction Enzymes | 3 | 1986 | 53 | 0.020 |
Why?
| | Phosphotyrosine | 2 | 2002 | 39 | 0.020 |
Why?
| | Immunoassay | 2 | 1989 | 109 | 0.020 |
Why?
| | Adolescent | 4 | 2016 | 22453 | 0.020 |
Why?
| | Vinblastine | 3 | 1976 | 75 | 0.020 |
Why?
| | Vaccinia virus | 2 | 2001 | 34 | 0.020 |
Why?
| | Nucleocapsid Proteins | 1 | 2011 | 28 | 0.020 |
Why?
| | Viral Core Proteins | 1 | 2011 | 22 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2014 | 1311 | 0.020 |
Why?
| | Methionine | 1 | 1992 | 162 | 0.020 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2011 | 16 | 0.020 |
Why?
| | Child | 4 | 2016 | 22657 | 0.020 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 2011 | 15 | 0.020 |
Why?
| | Mice, Inbred NZB | 2 | 2007 | 16 | 0.020 |
Why?
| | Cell Adhesion | 3 | 1999 | 455 | 0.020 |
Why?
| | Carbohydrates | 1 | 1991 | 66 | 0.020 |
Why?
| | Rosette Formation | 2 | 1980 | 14 | 0.020 |
Why?
| | Rats | 5 | 2000 | 5614 | 0.020 |
Why?
| | Bone Marrow Transplantation | 2 | 1992 | 294 | 0.020 |
Why?
| | Proteomics | 1 | 2018 | 1195 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Minor Histocompatibility Loci | 1 | 1990 | 3 | 0.020 |
Why?
| | Mutant Chimeric Proteins | 1 | 2010 | 6 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 72 | 0.020 |
Why?
| | Cellular Senescence | 1 | 1993 | 226 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 1992 | 342 | 0.020 |
Why?
| | Milk | 1 | 1991 | 119 | 0.020 |
Why?
| | Depression, Chemical | 1 | 1990 | 16 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 87 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 56 | 0.020 |
Why?
| | Lysine | 1 | 2012 | 302 | 0.020 |
Why?
| | Epoprostenol | 1 | 1991 | 131 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2009 | 11 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 27 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 52 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 91 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1993 | 284 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 166 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 2009 | 117 | 0.020 |
Why?
| | Antioxidants | 2 | 2003 | 549 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 2012 | 260 | 0.020 |
Why?
| | Fibrinogen | 1 | 2010 | 177 | 0.020 |
Why?
| | Chromosome Deletion | 4 | 1991 | 124 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 119 | 0.020 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 21 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2013 | 528 | 0.020 |
Why?
| | Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| | Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.020 |
Why?
| | Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.020 |
Why?
| | Disulfides | 3 | 2003 | 96 | 0.020 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 13 | 0.020 |
Why?
| | Caspase 1 | 1 | 2009 | 148 | 0.020 |
Why?
| | Goats | 3 | 1973 | 25 | 0.020 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2011 | 264 | 0.020 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 15 | 0.020 |
Why?
| | Phosphorylcholine | 1 | 1988 | 19 | 0.020 |
Why?
| | Integrin alpha4 | 1 | 2008 | 7 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 1990 | 178 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2008 | 56 | 0.020 |
Why?
| | Cell Nucleus | 2 | 1985 | 619 | 0.020 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 46 | 0.020 |
Why?
| | Eosinophils | 2 | 2004 | 316 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2009 | 93 | 0.020 |
Why?
| | Genes, Switch | 1 | 1988 | 6 | 0.020 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2008 | 25 | 0.020 |
Why?
| | Genes, Regulator | 1 | 1988 | 35 | 0.020 |
Why?
| | Antigens, Helminth | 1 | 2008 | 16 | 0.020 |
Why?
| | Shock, Septic | 1 | 1990 | 216 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2013 | 529 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2009 | 169 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 16 | 0.020 |
Why?
| | Schistosoma mansoni | 1 | 2008 | 41 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8279 | 0.020 |
Why?
| | Mannose | 1 | 1987 | 23 | 0.020 |
Why?
| | Hexosaminidases | 1 | 1987 | 16 | 0.020 |
Why?
| | Introns | 1 | 1988 | 254 | 0.020 |
Why?
| | Nitrobenzenes | 3 | 1976 | 17 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2009 | 139 | 0.020 |
Why?
| | Antigens, CD1 | 1 | 2007 | 60 | 0.020 |
Why?
| | Leukemia P388 | 2 | 1984 | 7 | 0.020 |
Why?
| | Fluoresceins | 2 | 2004 | 48 | 0.020 |
Why?
| | Infection Control | 1 | 2009 | 172 | 0.020 |
Why?
| | Oligosaccharides | 1 | 1987 | 60 | 0.020 |
Why?
| | Genetic Variation | 2 | 1990 | 984 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 726 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 464 | 0.020 |
Why?
| | Hypersensitivity, Delayed | 3 | 1978 | 29 | 0.020 |
Why?
| | Pepsin A | 1 | 1986 | 18 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2006 | 55 | 0.020 |
Why?
| | Immunologic Techniques | 2 | 1983 | 38 | 0.020 |
Why?
| | Antibodies, Antinuclear | 1 | 2006 | 62 | 0.020 |
Why?
| | Health | 1 | 2007 | 81 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 2 | 2000 | 116 | 0.020 |
Why?
| | Antigens, T-Independent | 2 | 1983 | 5 | 0.020 |
Why?
| | Half-Life | 2 | 1977 | 151 | 0.020 |
Why?
| | Proteinuria | 1 | 2006 | 102 | 0.010 |
Why?
| | Leukopoiesis | 1 | 2006 | 11 | 0.010 |
Why?
| | Transgenes | 2 | 1997 | 190 | 0.010 |
Why?
| | Weight Loss | 1 | 1992 | 837 | 0.010 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 105 | 0.010 |
Why?
| | Lymphoma | 5 | 1985 | 233 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2006 | 128 | 0.010 |
Why?
| | Body Weight | 1 | 1990 | 978 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1985 | 200 | 0.010 |
Why?
| | Guinea Pigs | 2 | 1977 | 159 | 0.010 |
Why?
| | Prostaglandins E | 1 | 1985 | 33 | 0.010 |
Why?
| | Drug Synergism | 2 | 1983 | 357 | 0.010 |
Why?
| | Liposomes | 2 | 2002 | 250 | 0.010 |
Why?
| | Cytoplasm | 1 | 1985 | 269 | 0.010 |
Why?
| | Succinimides | 1 | 2004 | 21 | 0.010 |
Why?
| | Protein Denaturation | 1 | 1984 | 75 | 0.010 |
Why?
| | Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.010 |
Why?
| | Immunoglobulin Light Chains | 1 | 1984 | 51 | 0.010 |
Why?
| | Freund's Adjuvant | 1 | 2004 | 18 | 0.010 |
Why?
| | Interphase | 2 | 2000 | 38 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2004 | 277 | 0.010 |
Why?
| | B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 3 | 0.010 |
Why?
| | Albumins | 1 | 1984 | 118 | 0.010 |
Why?
| | Genetic Markers | 1 | 1985 | 331 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1984 | 160 | 0.010 |
Why?
| | Antigens, Differentiation | 2 | 1997 | 77 | 0.010 |
Why?
| | Leukemia, Experimental | 1 | 1983 | 27 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 1983 | 30 | 0.010 |
Why?
| | Macrophage-Activating Factors | 1 | 1983 | 3 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 2114 | 0.010 |
Why?
| | Hemagglutination Tests | 2 | 1973 | 7 | 0.010 |
Why?
| | Catalase | 1 | 2003 | 130 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 12 | 0.010 |
Why?
| | United States | 1 | 2001 | 15988 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 2 | 1999 | 187 | 0.010 |
Why?
| | Receptors, CCR5 | 1 | 2003 | 60 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 161 | 0.010 |
Why?
| | Lung Diseases | 1 | 2010 | 787 | 0.010 |
Why?
| | Fas Ligand Protein | 1 | 2003 | 60 | 0.010 |
Why?
| | Karyotyping | 1 | 1983 | 106 | 0.010 |
Why?
| | Birds | 1 | 1983 | 92 | 0.010 |
Why?
| | Incidence | 1 | 2010 | 2883 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 77 | 0.010 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2002 | 10 | 0.010 |
Why?
| | Graft Rejection | 1 | 1986 | 540 | 0.010 |
Why?
| | Lod Score | 1 | 2002 | 62 | 0.010 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| | Lymphocyte Culture Test, Mixed | 3 | 1990 | 51 | 0.010 |
Why?
| | Prognosis | 1 | 1991 | 4293 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2002 | 194 | 0.010 |
Why?
| | Sex Chromosome Aberrations | 1 | 1981 | 69 | 0.010 |
Why?
| | CD79 Antigens | 1 | 2001 | 16 | 0.010 |
Why?
| | Virus Assembly | 1 | 2002 | 81 | 0.010 |
Why?
| | Fetal Blood | 1 | 1983 | 342 | 0.010 |
Why?
| | Growth Inhibitors | 1 | 2001 | 39 | 0.010 |
Why?
| | Myoglobin | 1 | 2000 | 12 | 0.010 |
Why?
| | Organ Specificity | 1 | 2001 | 313 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 276 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2001 | 252 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2000 | 35 | 0.010 |
Why?
| | Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| | Aspartic Acid | 1 | 2001 | 88 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 2000 | 83 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 852 | 0.010 |
Why?
| | Biopolymers | 1 | 2000 | 35 | 0.010 |
Why?
| | Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2007 | 962 | 0.010 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 12 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2000 | 58 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 2000 | 63 | 0.010 |
Why?
| | Staining and Labeling | 2 | 1980 | 151 | 0.010 |
Why?
| | Models, Biological | 2 | 2001 | 1822 | 0.010 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 20 | 0.010 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2000 | 61 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2000 | 109 | 0.010 |
Why?
| | Receptors, Interleukin-6 | 1 | 2000 | 47 | 0.010 |
Why?
| | Septins | 1 | 2000 | 43 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 319 | 0.010 |
Why?
| | STAT1 Transcription Factor | 1 | 2000 | 68 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| | Lyme Disease | 1 | 2000 | 58 | 0.010 |
Why?
| | GTP-Binding Proteins | 1 | 2000 | 153 | 0.010 |
Why?
| | Indicators and Reagents | 1 | 2000 | 106 | 0.010 |
Why?
| | Cell Lineage | 1 | 2001 | 376 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1999 | 101 | 0.010 |
Why?
| | Lymphocyte Transfusion | 1 | 1999 | 20 | 0.010 |
Why?
| | Multigene Family | 2 | 1991 | 204 | 0.010 |
Why?
| | Leukemia L1210 | 1 | 1999 | 7 | 0.010 |
Why?
| | Androstadienes | 1 | 1999 | 76 | 0.010 |
Why?
| | Lymphopenia | 1 | 1999 | 65 | 0.010 |
Why?
| | Child, Preschool | 2 | 1993 | 11799 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 153 | 0.010 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 82 | 0.010 |
Why?
| | Tissue Distribution | 2 | 1993 | 334 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 138 | 0.010 |
Why?
| | Manganese | 1 | 1999 | 55 | 0.010 |
Why?
| | Metalloporphyrins | 1 | 1999 | 66 | 0.010 |
Why?
| | Cholic Acids | 1 | 1998 | 13 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2000 | 402 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 175 | 0.010 |
Why?
| | Detergents | 1 | 1998 | 44 | 0.010 |
Why?
| | Absorption | 2 | 1975 | 60 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 266 | 0.010 |
Why?
| | Membrane Potentials | 1 | 1999 | 280 | 0.010 |
Why?
| | STAT3 Transcription Factor | 1 | 2000 | 207 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 292 | 0.010 |
Why?
| | Polysaccharides, Bacterial | 2 | 1975 | 67 | 0.010 |
Why?
| | Histocompatibility | 1 | 1977 | 21 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 749 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 1999 | 418 | 0.010 |
Why?
| | Isoantigens | 1 | 1977 | 17 | 0.010 |
Why?
| | Endocytosis | 1 | 1998 | 168 | 0.010 |
Why?
| | STAT6 Transcription Factor | 1 | 1997 | 24 | 0.010 |
Why?
| | Hybridization, Genetic | 1 | 1978 | 74 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 1999 | 381 | 0.010 |
Why?
| | Abatacept | 1 | 1997 | 56 | 0.010 |
Why?
| | Interleukins | 1 | 1999 | 248 | 0.010 |
Why?
| | Autoanalysis | 1 | 1977 | 8 | 0.010 |
Why?
| | Trypan Blue | 1 | 1977 | 5 | 0.010 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 1977 | 37 | 0.010 |
Why?
| | Whole-Body Irradiation | 1 | 1997 | 76 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 185 | 0.010 |
Why?
| | CTLA-4 Antigen | 1 | 1997 | 104 | 0.010 |
Why?
| | Warfarin | 1 | 1978 | 170 | 0.010 |
Why?
| | Infant | 1 | 1991 | 10039 | 0.010 |
Why?
| | Genetic Complementation Test | 2 | 1986 | 66 | 0.010 |
Why?
| | Antigen-Antibody Complex | 2 | 1987 | 72 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 826 | 0.010 |
Why?
| | Immunity, Mucosal | 1 | 1997 | 98 | 0.010 |
Why?
| | Sequence Homology | 1 | 1995 | 43 | 0.010 |
Why?
| | Radiation Effects | 1 | 1975 | 7 | 0.010 |
Why?
| | Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| | Surface Properties | 1 | 1976 | 410 | 0.010 |
Why?
| | Trachea | 1 | 1997 | 261 | 0.010 |
Why?
| | Skin Tests | 1 | 1975 | 94 | 0.010 |
Why?
| | Methods | 1 | 1974 | 69 | 0.010 |
Why?
| | Complement System Proteins | 2 | 1974 | 316 | 0.010 |
Why?
| | Transferrin | 1 | 1993 | 50 | 0.010 |
Why?
| | Hindlimb | 1 | 1974 | 131 | 0.010 |
Why?
| | Umbilical Cord | 1 | 1994 | 91 | 0.010 |
Why?
| | Transplantation Immunology | 1 | 1993 | 29 | 0.010 |
Why?
| | Cell Transplantation | 1 | 1993 | 39 | 0.010 |
Why?
| | Viral Plaque Assay | 1 | 1973 | 29 | 0.010 |
Why?
| | Immunoglobulin M | 1 | 1975 | 284 | 0.010 |
Why?
| | Bufo marinus | 1 | 1973 | 1 | 0.010 |
Why?
| | Animals, Newborn | 2 | 1988 | 902 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 2 | 1983 | 51 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1993 | 85 | 0.010 |
Why?
| | Fetal Tissue Transplantation | 1 | 1992 | 33 | 0.010 |
Why?
| | Pedigree | 1 | 1994 | 514 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1993 | 191 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1992 | 93 | 0.010 |
Why?
| | Disease | 1 | 1993 | 98 | 0.010 |
Why?
| | Models, Structural | 1 | 1991 | 41 | 0.010 |
Why?
| | Ionomycin | 1 | 1991 | 22 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1992 | 141 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1991 | 153 | 0.010 |
Why?
| | Liver | 2 | 1992 | 1888 | 0.010 |
Why?
| | DNA Methylation | 1 | 1996 | 683 | 0.010 |
Why?
| | 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 18 | 0.010 |
Why?
| | Calcimycin | 1 | 1991 | 36 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1991 | 204 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 1973 | 231 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 1997 | 965 | 0.010 |
Why?
| | Arthritis | 1 | 1991 | 96 | 0.010 |
Why?
| | Receptors, Leukocyte-Adhesion | 1 | 1990 | 2 | 0.000 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 9 | 0.000 |
Why?
| | Thymidine | 1 | 1970 | 60 | 0.000 |
Why?
| | Oligonucleotide Probes | 1 | 1990 | 50 | 0.000 |
Why?
| | Immunotherapy, Adoptive | 1 | 1993 | 337 | 0.000 |
Why?
| | Amidohydrolases | 1 | 1990 | 32 | 0.000 |
Why?
| | RNA Splicing | 1 | 1991 | 285 | 0.000 |
Why?
| | Cytosine | 1 | 1970 | 51 | 0.000 |
Why?
| | Carbon Isotopes | 1 | 1970 | 144 | 0.000 |
Why?
| | Cricetulus | 1 | 1989 | 118 | 0.000 |
Why?
| | Reference Values | 1 | 1990 | 798 | 0.000 |
Why?
| | Extracellular Space | 1 | 1989 | 120 | 0.000 |
Why?
| | Gestational Age | 1 | 1992 | 975 | 0.000 |
Why?
| | Adrenergic beta-Antagonists | 1 | 1970 | 250 | 0.000 |
Why?
| | Cross-Linking Reagents | 1 | 1989 | 207 | 0.000 |
Why?
| | Microspheres | 1 | 1988 | 142 | 0.000 |
Why?
| | Bacteriophage lambda | 1 | 1988 | 90 | 0.000 |
Why?
| | Leukocyte Count | 1 | 1988 | 316 | 0.000 |
Why?
| | Enhancer Elements, Genetic | 1 | 1988 | 192 | 0.000 |
Why?
| | Glass | 1 | 1986 | 46 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1990 | 390 | 0.000 |
Why?
| | Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| | Liver Transplantation | 1 | 1992 | 823 | 0.000 |
Why?
| | Transformation, Genetic | 1 | 1985 | 15 | 0.000 |
Why?
| | Mast-Cell Sarcoma | 1 | 1985 | 6 | 0.000 |
Why?
| | Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1984 | 1 | 0.000 |
Why?
| | Mesylates | 1 | 1984 | 7 | 0.000 |
Why?
| | Acetylglucosaminidase | 1 | 1984 | 8 | 0.000 |
Why?
| | Sezary Syndrome | 1 | 1984 | 45 | 0.000 |
Why?
| | Membranes, Artificial | 1 | 1984 | 75 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1984 | 321 | 0.000 |
Why?
| | Thymus Neoplasms | 1 | 1984 | 27 | 0.000 |
Why?
| | Isoelectric Point | 1 | 1984 | 23 | 0.000 |
Why?
| | Bacteria | 1 | 1991 | 889 | 0.000 |
Why?
| | Fixatives | 1 | 1983 | 13 | 0.000 |
Why?
| | Glutaral | 1 | 1983 | 13 | 0.000 |
Why?
| | Cell-Free System | 1 | 1983 | 53 | 0.000 |
Why?
| | Receptors, Antigen | 1 | 1983 | 14 | 0.000 |
Why?
| | Chemical Precipitation | 1 | 1983 | 39 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1990 | 2947 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1993 | 2738 | 0.000 |
Why?
| | X Chromosome | 1 | 1981 | 67 | 0.000 |
Why?
| | Pulmonary Alveoli | 1 | 1983 | 383 | 0.000 |
Why?
| | Brain | 1 | 1993 | 2941 | 0.000 |
Why?
| | Magnetic Resonance Imaging | 1 | 1993 | 3869 | 0.000 |
Why?
| | Polymers | 1 | 1983 | 499 | 0.000 |
Why?
| | Pregnancy | 1 | 1992 | 7191 | 0.000 |
Why?
| | Sarcoma, Experimental | 1 | 1974 | 6 | 0.000 |
Why?
| | Immunoglobulin Fragments | 1 | 1974 | 11 | 0.000 |
Why?
|
|
Kappler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|